Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft‐versus‐host disease and survival outcome

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|36|1|276-284

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 276-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation

By McDonald George B  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1709-1724

Informa Healthcare

Access to resources Recommend Favorite

Chronic Graft-Versus-Host Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. : 1974-1986

Bentham Science Publishers

Access to resources Recommend Favorite

Denileukin diftitox has promising activity in graft-versus-host disease (GVHD) following haematopoietic stem cell transplantation

By  

Inpharma, Vol. 1, Iss. 1458, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation

By Servais Sophie   Beguin Yves   Baron Frédéric  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 173-192

Informa Healthcare

Access to resources Recommend Favorite

Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for graft-versus-host disease in allogeneic antitumor cell therapy

By Lum Lawrence G   Yang Wen  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 4, 2007-04 ,pp. : 459-464

Informa Healthcare

Access to resources Recommend Favorite